| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -141,9 k € | -7.4% | -132,2 k € | -16.2% | -113,7 k € | -8.1% | -105,2 k € | +30.2% | -150,6 k € | |
| EBITDA | -143,2 k € | -7.4% | -133,4 k € | -15.9% | -115,1 k € | -8.9% | -105,7 k € | +30.3% | -151,7 k € | |
| Operating profit | -152,8 k € | -6.7% | -143,2 k € | -14.6% | -124,9 k € | -8.1% | -115,5 k € | +28.6% | -161,7 k € | |
| Profit/loss | -887,1 k € | -1063.1% | 92,1 k € | +126.0% | -354,7 k € | -14.3% | -310,4 k € | +60.0% | -776,3 k € | |
| Equity | 13,0 M € | +12.5% | 11,5 M € | +26.5% | 9,1 M € | -3.7% | 9,5 M € | +84.8% | 5,1 M € | |
| Total assets | 13,1 M € | +12.4% | 11,6 M € | +26.9% | 9,2 M € | -4.1% | 9,5 M € | +84.3% | 5,2 M € | |
| Cash | 1,1 M € | -17.0% | 1,3 M € | +3690.6% | 35,5 k € | -98.6% | 2,6 M € | +241.2% | 755,0 k € | |
| Debts | 68,5 k € | +1.1% | 67,7 k € | +141.6% | 28,0 k € | -58.4% | 67,4 k € | +32.6% | 50,8 k € | |
| Staff | 0 | 0 | 0 | — | — | |||||
Limited partnership · Roeselare · incorporated on 02/12/2020 · 0,0 ETP
Limited partnership loss-making in the latest fiscal year. Cash position declining (-17.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
QUAESTOR BIOTECH is a Limited partnership incorporated in 2020. Its registered office is in Roeselare.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette